Kinins in pain and inflammation

被引:233
作者
Calixto, JB [1 ]
Cabrini, DA [1 ]
Ferreira, J [1 ]
Campos, MM [1 ]
机构
[1] Univ Fed Santa Catarina, Dept Farmacol, Ctr Biol Sci, BR-88015420 Florianopolis, SC, Brazil
关键词
D O I
10.1016/S0304-3959(00)00335-3
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
[No abstract available]
引用
收藏
页码:1 / 5
页数:5
相关论文
共 39 条
[1]  
Ahluwalia A, 1996, J IMMUNOL, V156, P269
[2]   Effects of a nonpeptide bradykinin B-2 receptor antagonist, FR167344, on different in vivo animal models of inflammation [J].
Asano, M ;
Hatori, C ;
Inamura, N ;
Sawai, H ;
Hirosumi, J ;
Fujiwara, T ;
Nakahara, K .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 (07) :1436-1440
[3]  
BHOOLA KD, 1992, PHARMACOL REV, V44, P1
[4]   Nociception and inflammatory hyperalgesia in B-2 bradykinin receptor knockout mice [J].
Boyce, S ;
Rupniak, NMJ ;
Carlson, EJ ;
Webb, J ;
Borkowski, JA ;
Hess, JF ;
Strader, CD ;
Hill, RG .
IMMUNOPHARMACOLOGY, 1996, 33 (1-3) :333-335
[5]   Bradyzide, a potent non-peptide B2 bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesia [J].
Burgess, GM ;
Perkins, MN ;
Rang, HP ;
Campbell, EA ;
Brown, MC ;
McIntyre, P ;
Urban, L ;
Dziadulewicz, EK ;
Ritchie, TJ ;
Hallett, A ;
Snell, CR ;
Wrigglesworth, R ;
Lee, W ;
Davis, C ;
Phagoo, SB ;
Davis, AJ ;
Phillips, E ;
Drake, GS ;
Hughes, GA ;
Dunstan, A ;
Bloomfield, GC .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (01) :77-86
[6]   In vivo B1 kinin-receptor upregulation.: Evidence for involvement of protein kinases and nuclear factor κB pathways [J].
Campos, MM ;
Souza, GEP ;
Calixto, JB .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (08) :1851-1859
[7]   INVOLVEMENT OF B-1 AND B-2 RECEPTORS IN BRADYKININ-INDUCED RAT PAW EDEMA [J].
CAMPOS, MM ;
CALIXTO, JB .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (05) :1005-1013
[8]   Specific involvement of PKC-ε in sensitization of the neuronal response to painful heat [J].
Cesare, P ;
Dekker, LV ;
Sardini, A ;
Parker, PJ ;
McNaughton, PA .
NEURON, 1999, 23 (03) :617-624
[9]  
DECAMPOS ROP, 1999, N-S ARCH PHARMACOL, V360, P78
[10]  
Dray A., 1997, HDB IMMUNOPHARMACOLO, P157, DOI [10.1016/B978-012249340-9/50011-5, DOI 10.1016/B978-012249340-9/50011-5]